WAY

In September 2026, Kaskela Law Firm announced a stockholder investigation into Waystar, reports emerged that the company was considering a potential sale, and Barclays downgraded its stock from an 'overweight' to an 'equal weight' rating. Also in September 2026, CEO Matthew Hawkins sold 82,500 shares, with insider selling generally outweighing insider buying in the past three months. In October 2026, Waystar shares rose following the finalization of Transparency in Coverage rules by HHS/CMS. The company reported strong Second Quarter 2026 results in July, with revenue up 18% year-over-year to $319.7 million, net income of $40.9 million, an adjusted EBITDA margin of 43%, and raised its guidance for 2026. First Quarter 2026 results in April showed revenue of $313.9 million, up 22% year-over-year, and net income of $43.3 million. Over the last year, Waystar's stock decreased by 31.59%, but it has seen a 10.52% rise in the past month and a 5.58% rise in the past week as of October 8, 2026.